Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123283722 | 12328372 | 2 | F | 2006 | 20160919 | 20160503 | 20160923 | EXP | US-009507513-1605USA001360 | MERCK | 0.00 | M | Y | 120.64000 | KG | 20160923 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123283722 | 12328372 | 1 | PS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 5 MG, QD | Y | 20180 | 5 | MG | FILM-COATED TABLET | QD | |||||
| 123283722 | 12328372 | 2 | SS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 20 MG, QD | Y | 20180 | 20 | MG | FILM-COATED TABLET | QD | |||||
| 123283722 | 12328372 | 3 | SS | TAMSULOSIN HYDROCHLORIDE. | TAMSULOSIN HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | Y | 0 | |||||||||
| 123283722 | 12328372 | 4 | SS | TAMSULOSIN HYDROCHLORIDE. | TAMSULOSIN HYDROCHLORIDE | 1 | Y | 0 | |||||||||||
| 123283722 | 12328372 | 5 | C | LAMICTAL | LAMOTRIGINE | 1 | Oral | 100 MG, BID | 0 | 100 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123283722 | 12328372 | 1 | Benign prostatic hyperplasia |
| 123283722 | 12328372 | 2 | Urinary retention |
| 123283722 | 12328372 | 3 | Benign prostatic hyperplasia |
| 123283722 | 12328372 | 4 | Urinary retention |
| 123283722 | 12328372 | 5 | Bipolar disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123283722 | 12328372 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123283722 | 12328372 | Adverse drug reaction | |
| 123283722 | 12328372 | Adverse event | |
| 123283722 | 12328372 | Alopecia | |
| 123283722 | 12328372 | Amnesia | |
| 123283722 | 12328372 | Androgens abnormal | |
| 123283722 | 12328372 | Anger | |
| 123283722 | 12328372 | Anxiety | |
| 123283722 | 12328372 | Asthenia | |
| 123283722 | 12328372 | Blood glucose increased | |
| 123283722 | 12328372 | Breast enlargement | |
| 123283722 | 12328372 | Decreased interest | |
| 123283722 | 12328372 | Depression | |
| 123283722 | 12328372 | Disturbance in attention | |
| 123283722 | 12328372 | Dizziness | |
| 123283722 | 12328372 | Dry skin | |
| 123283722 | 12328372 | Erectile dysfunction | |
| 123283722 | 12328372 | Feeling abnormal | |
| 123283722 | 12328372 | Feelings of worthlessness | |
| 123283722 | 12328372 | Gynaecomastia | |
| 123283722 | 12328372 | Intentional overdose | |
| 123283722 | 12328372 | Irritability | |
| 123283722 | 12328372 | Listless | |
| 123283722 | 12328372 | Loss of libido | |
| 123283722 | 12328372 | Muscle atrophy | |
| 123283722 | 12328372 | Panic attack | |
| 123283722 | 12328372 | Penis disorder | |
| 123283722 | 12328372 | Prostatic specific antigen increased | |
| 123283722 | 12328372 | Secondary hypogonadism | |
| 123283722 | 12328372 | Sexual dysfunction | |
| 123283722 | 12328372 | Sleep disorder | |
| 123283722 | 12328372 | Sperm concentration decreased | |
| 123283722 | 12328372 | Testicular atrophy | |
| 123283722 | 12328372 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123283722 | 12328372 | 1 | 2006 | 201405 | 0 | |
| 123283722 | 12328372 | 2 | 2006 | 0 | ||
| 123283722 | 12328372 | 3 | 2006 | 2014 | 0 | |
| 123283722 | 12328372 | 5 | 2004 | 0 |